Tevra opposes Elanco move to dismiss US antitrust claims over flea, tick treatments
MLex Summary: Tevra Brands filed an opposition to dismissal of its US antitrust claims against Elanco Health, stating that its action is "distinct and different" from its previous claims against Bayer...To view the full article, register now.
Already a subscriber? Click here to view full article